Department of Medical Statistics, College of Medicine, Catholic University of Daegu, Daegu, Korea.
Department of Rehabilitation Medicine, College of Medicine, Yeungnam University, Daegu, Republic of Korea.
Pain Physician. 2023 Mar;26(2):113-123.
Epidural injection (EI) has been used to manage lower back and radicular leg pain caused by a herniated lumbar disc. There are 3 types of EI techniques currently being used: transforaminal (TFEI), interlaminar (ILEI), and caudal epidural injections (CEI).
To evaluate the comparative effectiveness of TFEI, ILEI, and CEI in reducing pain and improving function in patients with HLD.
Systematic review and meta-analysis.
The PubMed, Embase, Cochrane Library, and Scopus databases were searched from the earliest records up to August 2022 for randomized controlled trials (RCTs) and non-RCTs. The standard mean differences (SMDs) in the changes in the Visual Analog Scale (VAS) and Oswestry Disability Index (ODI) scores were calculated from one week through one month posttreatment (short-term) and from 4 months through 6 months posttreatment (long-term).
In total, 11 studies comprising 1,050 patients were included. Network meta-analysis showed that the improvement in the VAS scores was better with TFEI than with CEI (SMD = -1.16, 95% CI = -2.10 to -0.23). Ranking probability analysis showed that TFEI had the highest probability of being the best treatment for reducing pain and improving function in the short- and long-term evaluation periods.
Only a small number of previous studies were included in our analysis. Also, subgroup analysis according to the injection volume, material type, or pain onset could not be conducted.
TFEI had the best potential of the 3 EI techniques to reduce pain and improve function in patients with a herniated lumbar disc. Further qualified trials comparing the effects of these 3 techniques are warranted to derive definitive conclusions.
硬膜外注射(EI)已被用于治疗由腰椎间盘突出引起的下腰痛和神经根性腿痛。目前有 3 种类型的 EI 技术正在使用:经椎间孔(TFEI)、经椎间孔(ILEI)和骶管硬膜外注射(CEI)。
评估 TFEI、ILEI 和 CEI 在减轻腰椎间盘突出症患者疼痛和改善功能方面的比较效果。
系统评价和荟萃分析。
从最早的记录到 2022 年 8 月,检索 PubMed、Embase、Cochrane 图书馆和 Scopus 数据库,以查找随机对照试验(RCT)和非 RCT。从治疗后一周到一个月(短期)和 4 个月到 6 个月(长期)计算视觉模拟量表(VAS)和 Oswestry 残疾指数(ODI)评分变化的标准均数差(SMD)。
共纳入 11 项研究,共 1050 例患者。网络荟萃分析显示,TFEI 改善 VAS 评分优于 CEI(SMD=-1.16,95%CI=-2.10 至-0.23)。排序概率分析显示,TFEI 在短期和长期评估期间在减轻疼痛和改善功能方面最有可能成为最佳治疗方法。
我们的分析仅包括少数先前的研究。此外,根据注射量、材料类型或疼痛发作进行的亚组分析无法进行。
在 3 种 EI 技术中,TFEI 具有减轻腰椎间盘突出症患者疼痛和改善功能的最佳潜力。需要进一步进行比较这 3 种技术效果的高质量试验,以得出明确的结论。